8VDU
Crystal structure of hybrid insulin peptide (InsC8-15-IAPP74-80) bound to HLA-DQ8
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-11-26 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.9537 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 72.319, 138.116, 101.832 |
Unit cell angles | 90.00, 102.50, 90.00 |
Refinement procedure
Resolution | 49.040 - 3.500 |
R-factor | 0.2094 |
Rwork | 0.207 |
R-free | 0.24570 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.002 |
RMSD bond angle | 0.625 |
Data reduction software | autoXDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | PHENIX (1.19_4092) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.400 | 3.500 |
High resolution limit [Å] | 3.500 | 3.500 |
Number of reflections | 28794 | 4228 |
<I/σ(I)> | 4.6 | 2 |
Completeness [%] | 97.9 | |
Redundancy | 4.2 | |
CC(1/2) | 0.907 | 0.414 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 293.15 | 0.2 M Monopotassium phosphate, 17% PEG 8K |